BioNTech Gathering Data Supporting MammaTyper Over Manual, Digital IHC for Breast Cancer Subtyping

NEW YORK (GenomeWeb) – Supporting continued marketing of its breast cancer subtyping test MammaTyper, German MDx firm BioNTech Diagnostics published a study last month comparing the test for the first time with both visual and computer-assisted immunohistochemistry methods.

Get the full story with
GenomeWeb Premium Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Be the first to comment

Leave a Reply

Your email address will not be published.


*